Go Pro

USANA Health Sciences (USNA) Competitors

USANA Health Sciences logo
$15.43 +0.54 (+3.63%)
Closing price 03:59 PM Eastern
Extended Trading
$15.53 +0.10 (+0.62%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

USNA vs. OLPX, HLF, EPC, ODD, and BWMX

Should you buy USANA Health Sciences stock or one of its competitors? MarketBeat compares USANA Health Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with USANA Health Sciences include Olaplex (OLPX), Herbalife (HLF), Edgewell Personal Care (EPC), ODDITY Tech (ODD), and Betterware de Mexico SAPI de C (BWMX). These companies are all part of the "personal care products" industry.

How does USANA Health Sciences compare to Olaplex?

Olaplex (NASDAQ:OLPX) and USANA Health Sciences (NYSE:USNA) are both small-cap consumer staples companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

USANA Health Sciences has higher revenue and earnings than Olaplex. Olaplex is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Olaplex$425.35M3.27-$9.25M-$0.02N/A
USANA Health Sciences$925.26M0.31$10.76M-$1.21N/A

In the previous week, USANA Health Sciences had 20 more articles in the media than Olaplex. MarketBeat recorded 21 mentions for USANA Health Sciences and 1 mentions for Olaplex. USANA Health Sciences' average media sentiment score of 0.01 beat Olaplex's score of 0.00 indicating that USANA Health Sciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Olaplex
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
USANA Health Sciences
3 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

87.4% of Olaplex shares are held by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are held by institutional investors. 4.8% of Olaplex shares are held by company insiders. Comparatively, 0.8% of USANA Health Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

USANA Health Sciences has a net margin of -2.43% compared to Olaplex's net margin of -3.53%. USANA Health Sciences' return on equity of 3.41% beat Olaplex's return on equity.

Company Net Margins Return on Equity Return on Assets
Olaplex-3.53% 2.23% 1.31%
USANA Health Sciences -2.43%3.41%2.50%

Olaplex currently has a consensus price target of $1.92, indicating a potential downside of 7.11%. Given Olaplex's stronger consensus rating and higher probable upside, equities analysts plainly believe Olaplex is more favorable than USANA Health Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Olaplex
1 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
USANA Health Sciences
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Olaplex has a beta of 1.85, meaning that its share price is 85% more volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.73, meaning that its share price is 27% less volatile than the broader market.

Summary

Olaplex and USANA Health Sciences tied by winning 8 of the 16 factors compared between the two stocks.

How does USANA Health Sciences compare to Herbalife?

USANA Health Sciences (NYSE:USNA) and Herbalife (NYSE:HLF) are both small-cap consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

In the previous week, USANA Health Sciences had 6 more articles in the media than Herbalife. MarketBeat recorded 21 mentions for USANA Health Sciences and 15 mentions for Herbalife. Herbalife's average media sentiment score of 0.31 beat USANA Health Sciences' score of 0.01 indicating that Herbalife is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
USANA Health Sciences
3 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Herbalife
4 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

USANA Health Sciences has a beta of 0.73, meaning that its stock price is 27% less volatile than the broader market. Comparatively, Herbalife has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market.

Herbalife has a net margin of 3.16% compared to USANA Health Sciences' net margin of -2.43%. USANA Health Sciences' return on equity of 3.41% beat Herbalife's return on equity.

Company Net Margins Return on Equity Return on Assets
USANA Health Sciences-2.43% 3.41% 2.50%
Herbalife 3.16%-43.90%7.89%

Herbalife has higher revenue and earnings than USANA Health Sciences. USANA Health Sciences is trading at a lower price-to-earnings ratio than Herbalife, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
USANA Health Sciences$925.26M0.31$10.76M-$1.21N/A
Herbalife$5.04B0.25$228.30M$1.557.96

54.3% of USANA Health Sciences shares are owned by institutional investors. 0.8% of USANA Health Sciences shares are owned by company insiders. Comparatively, 5.1% of Herbalife shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Herbalife has a consensus target price of $17.00, suggesting a potential upside of 37.84%. Given Herbalife's stronger consensus rating and higher possible upside, analysts clearly believe Herbalife is more favorable than USANA Health Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
USANA Health Sciences
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Herbalife
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43

Summary

Herbalife beats USANA Health Sciences on 12 of the 16 factors compared between the two stocks.

How does USANA Health Sciences compare to Edgewell Personal Care?

Edgewell Personal Care (NYSE:EPC) and USANA Health Sciences (NYSE:USNA) are both small-cap consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

In the previous week, USANA Health Sciences had 2 more articles in the media than Edgewell Personal Care. MarketBeat recorded 21 mentions for USANA Health Sciences and 19 mentions for Edgewell Personal Care. Edgewell Personal Care's average media sentiment score of 1.18 beat USANA Health Sciences' score of 0.01 indicating that Edgewell Personal Care is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Edgewell Personal Care
11 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
USANA Health Sciences
3 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

91.9% of Edgewell Personal Care shares are owned by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are owned by institutional investors. 3.0% of Edgewell Personal Care shares are owned by company insiders. Comparatively, 0.8% of USANA Health Sciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

USANA Health Sciences has a net margin of -2.43% compared to Edgewell Personal Care's net margin of -4.55%. Edgewell Personal Care's return on equity of 5.76% beat USANA Health Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Edgewell Personal Care-4.55% 5.76% 2.35%
USANA Health Sciences -2.43%3.41%2.50%

Edgewell Personal Care has a beta of 0.39, suggesting that its share price is 61% less volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.73, suggesting that its share price is 27% less volatile than the broader market.

Edgewell Personal Care currently has a consensus target price of $31.83, suggesting a potential upside of 11.99%. Given Edgewell Personal Care's stronger consensus rating and higher possible upside, equities research analysts clearly believe Edgewell Personal Care is more favorable than USANA Health Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Edgewell Personal Care
1 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.25
USANA Health Sciences
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Edgewell Personal Care has higher revenue and earnings than USANA Health Sciences. Edgewell Personal Care is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edgewell Personal Care$2.22B0.59$25.40M-$1.67N/A
USANA Health Sciences$925.26M0.31$10.76M-$1.21N/A

Summary

Edgewell Personal Care beats USANA Health Sciences on 10 of the 16 factors compared between the two stocks.

How does USANA Health Sciences compare to ODDITY Tech?

USANA Health Sciences (NYSE:USNA) and ODDITY Tech (NASDAQ:ODD) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

ODDITY Tech has a consensus price target of $25.39, suggesting a potential upside of 79.79%. Given ODDITY Tech's stronger consensus rating and higher possible upside, analysts clearly believe ODDITY Tech is more favorable than USANA Health Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
USANA Health Sciences
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
ODDITY Tech
4 Sell rating(s)
9 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.69

In the previous week, USANA Health Sciences had 11 more articles in the media than ODDITY Tech. MarketBeat recorded 21 mentions for USANA Health Sciences and 10 mentions for ODDITY Tech. ODDITY Tech's average media sentiment score of 0.98 beat USANA Health Sciences' score of 0.01 indicating that ODDITY Tech is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
USANA Health Sciences
3 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
ODDITY Tech
5 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

USANA Health Sciences has a beta of 0.73, indicating that its share price is 27% less volatile than the broader market. Comparatively, ODDITY Tech has a beta of 2.38, indicating that its share price is 138% more volatile than the broader market.

54.3% of USANA Health Sciences shares are owned by institutional investors. Comparatively, 35.9% of ODDITY Tech shares are owned by institutional investors. 0.8% of USANA Health Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

ODDITY Tech has a net margin of 6.97% compared to USANA Health Sciences' net margin of -2.43%. ODDITY Tech's return on equity of 15.38% beat USANA Health Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
USANA Health Sciences-2.43% 3.41% 2.50%
ODDITY Tech 6.97%15.38%4.99%

ODDITY Tech has lower revenue, but higher earnings than USANA Health Sciences. USANA Health Sciences is trading at a lower price-to-earnings ratio than ODDITY Tech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
USANA Health Sciences$925.26M0.31$10.76M-$1.21N/A
ODDITY Tech$809.84M1.00$110.75M$0.7917.87

Summary

ODDITY Tech beats USANA Health Sciences on 11 of the 15 factors compared between the two stocks.

How does USANA Health Sciences compare to Betterware de Mexico SAPI de C?

Betterware de Mexico SAPI de C (NYSE:BWMX) and USANA Health Sciences (NYSE:USNA) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

12.7% of Betterware de Mexico SAPI de C shares are owned by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are owned by institutional investors. 0.8% of USANA Health Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Betterware de Mexico SAPI de C has a net margin of 8.35% compared to USANA Health Sciences' net margin of -2.43%. Betterware de Mexico SAPI de C's return on equity of 77.89% beat USANA Health Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Betterware de Mexico SAPI de C8.35% 77.89% 11.28%
USANA Health Sciences -2.43%3.41%2.50%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Betterware de Mexico SAPI de C
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.33
USANA Health Sciences
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Betterware de Mexico SAPI de C has a beta of 1.05, meaning that its stock price is 5% more volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.73, meaning that its stock price is 27% less volatile than the broader market.

In the previous week, USANA Health Sciences had 17 more articles in the media than Betterware de Mexico SAPI de C. MarketBeat recorded 21 mentions for USANA Health Sciences and 4 mentions for Betterware de Mexico SAPI de C. Betterware de Mexico SAPI de C's average media sentiment score of 1.03 beat USANA Health Sciences' score of 0.01 indicating that Betterware de Mexico SAPI de C is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Betterware de Mexico SAPI de C
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
USANA Health Sciences
3 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Betterware de Mexico SAPI de C has higher earnings, but lower revenue than USANA Health Sciences. USANA Health Sciences is trading at a lower price-to-earnings ratio than Betterware de Mexico SAPI de C, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Betterware de Mexico SAPI de C$744M0.84$55.37M$1.839.16
USANA Health Sciences$925.26M0.31$10.76M-$1.21N/A

Summary

Betterware de Mexico SAPI de C beats USANA Health Sciences on 11 of the 15 factors compared between the two stocks.

Get USANA Health Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for USNA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding USNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

USNA vs. The Competition

MetricUSANA Health SciencesPersonal Care Products IndustryConsumer Staples SectorNYSE Exchange
Market Cap$274.91M$22.95B$16.19B$24.08B
Dividend YieldN/A4.33%3.20%3.71%
P/E Ratio-12.7515.7914.0929.18
Price / Sales0.3112.93263,621.2419.20
Price / Cash3.6029.4157.6632.96
Price / Book0.542.824.636.87
Net Income$10.76M$1.08B$838.44M$1.06B
7 Day Performance-30.08%3.66%0.66%2.90%
1 Month Performance-30.96%-2.59%-0.19%2.54%
1 Year Performance-46.78%-16.51%13.04%20.37%

USANA Health Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
USNA
USANA Health Sciences
1.3841 of 5 stars
$15.43
+3.6%
N/A-48.9%$274.91M$925.26MN/A1,570
OLPX
Olaplex
0.962 of 5 stars
$2.07
flat
$1.92
-7.1%
N/A$1.39B$425.35MN/A170
HLF
Herbalife
4.0886 of 5 stars
$12.72
+2.4%
$17.80
+40.0%
+24.1%$1.29B$5.04B5.588,500
EPC
Edgewell Personal Care
3.205 of 5 stars
$27.70
+1.9%
$28.00
+1.1%
+28.4%$1.25B$2.22BN/A6,700
ODD
ODDITY Tech
3.9265 of 5 stars
$15.23
+7.4%
$25.39
+66.7%
-76.7%$816.41M$809.84M19.28342

Related Companies and Tools


This page (NYSE:USNA) was last updated on 8/7/2026 by MarketBeat.com Staff.
From Our Partners